Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.

Laforest R, Dehdashti F, Lewis JS, Schwarz SW.

Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):764-70. Epub 2005 Mar 23.

PMID:
15785955
2.

Dosimetry of 64Cu-DOTA-AE105, a PET tracer for uPAR imaging.

Persson M, El Ali HH, Binderup T, Pfeifer A, Madsen J, Rasmussen P, Kjaer A.

Nucl Med Biol. 2014 Mar;41(3):290-5. doi: 10.1016/j.nucmedbio.2013.12.007. Epub 2013 Dec 18.

3.

Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.

Tolvanen T, Någren K, Yu M, Sutinen E, Havu-Aurén K, Jyrkkiö S, Asola M, Kotoneva E, Nuutila P, Minn H.

Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1178-84. Epub 2006 May 24.

PMID:
16721566
4.

Human Biodistribution and Radiation Dosimetry of S-11C-Methyl-L-Cysteine Using Whole-Body PET.

Yao B, Tang C, Tang G, Hu K, Liang X, Shi X, Nie D, Tang X, Yue D.

Clin Nucl Med. 2015 Oct;40(10):e470-4. doi: 10.1097/RLU.0000000000000738.

PMID:
25742235
5.

High purity production and potential applications of copper-60 and copper-61.

McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ.

Nucl Med Biol. 1999 May;26(4):351-8.

PMID:
10382836
6.

Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.

Cutler PD, Schwarz SW, Anderson CJ, Connett JM, Welch MJ, Philpott GW, Siegel BA.

J Nucl Med. 1995 Dec;36(12):2363-71.

7.

18F-Fluorothymidine radiation dosimetry in human PET imaging studies.

Vesselle H, Grierson J, Peterson LM, Muzi M, Mankoff DA, Krohn KA.

J Nucl Med. 2003 Sep;44(9):1482-8.

8.

PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.

Makris NE, Boellaard R, van Lingen A, Lammertsma AA, van Dongen GA, Verheul HM, Menke CW, Huisman MC.

J Nucl Med. 2015 Feb;56(2):249-54. doi: 10.2967/jnumed.114.147819. Epub 2015 Jan 22.

9.

An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix.

Lewis JS, Laforest R, Dehdashti F, Grigsby PW, Welch MJ, Siegel BA.

J Nucl Med. 2008 Jul;49(7):1177-82. doi: 10.2967/jnumed.108.051326. Epub 2008 Jun 13.

10.

Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.

Tolvanen T, Yli-Kerttula T, Ujula T, Autio A, Lehikoinen P, Minn H, Roivainen A.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):874-83. doi: 10.1007/s00259-009-1346-z. Epub 2010 Jan 13.

PMID:
20069295
11.

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.

Rizvi SN, Visser OJ, Vosjan MJ, van Lingen A, Hoekstra OS, Zijlstra JM, Huijgens PC, van Dongen GA, Lubberink M.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):512-20. doi: 10.1007/s00259-011-2008-5. Epub 2012 Jan 5.

12.

Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.

Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M, Moresco RM.

J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22.

13.

Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.

Yoshii Y, Matsumoto H, Yoshimoto M, Furukawa T, Morokoshi Y, Sogawa C, Zhang MR, Wakizaka H, Yoshii H, Fujibayashi Y, Saga T.

PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014.

14.

Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.

Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO.

J Nucl Med. 2007 Jan;48(1):128-33.

15.

Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.

Bretin F, Bahri MA, Bernard C, Warnock G, Aerts J, Mestdagh N, Buchanan T, Otoul C, Koestler F, Mievis F, Giacomelli F, Degueldre C, Hustinx R, Luxen A, Seret A, Plenevaux A, Salmon E.

Mol Imaging Biol. 2015 Aug;17(4):557-64. doi: 10.1007/s11307-014-0820-6.

PMID:
25595813
16.

Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging.

Jalilian AR, Rostampour N, Rowshanfarzad P, Shafaii K, Kamali-Dehghan M, Akhlaghi M.

Acta Pharm. 2009 Mar;59(1):45-55. doi: 10.2478/v10007-009-0008-9.

PMID:
19304557
17.

Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).

Yuan H, Schroeder T, Bowsher JE, Hedlund LW, Wong T, Dewhirst MW.

J Nucl Med. 2006 Jun;47(6):989-98.

18.

Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.

Peng F, Lutsenko S, Sun X, Muzik O.

Mol Imaging Biol. 2012 Feb;14(1):70-8. doi: 10.1007/s11307-011-0476-4.

19.

18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.

Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.

J Nucl Med. 2013 Sep;54(9):1551-6. doi: 10.2967/jnumed.112.118760. Epub 2013 Aug 15.

20.

Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.

Handley MG, Medina RA, Mariotti E, Kenny GD, Shaw KP, Yan R, Eykyn TR, Blower PJ, Southworth R.

J Nucl Med. 2014 Mar;55(3):488-94. doi: 10.2967/jnumed.113.129015. Epub 2014 Jan 13.

Supplemental Content

Support Center